Royalty Pharma (RPRX) Equity Income (2019 - 2026)
Royalty Pharma (RPRX) posted Equity Income of $4.08 million for Q2 2026, up 51.4% from $2.69 million a year earlier but down 81.3% from the prior quarter.
Powered by 
Analysis
Royalty Pharma (RPRX) Equity Income (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Equity Income at Royalty Pharma was $45.79 million, down 10.6% year-over-year; for FY2025, it came in at $29.09 million, down 1.8% from FY2024.
- Annual Equity Income shows a five-year compound annual growth rate of -8.1% (FY2020 to FY2025).
- In prior years, Royalty Pharma's Equity Income was $29.61 million in FY2024 (+2.5%), $28.88 million in FY2023, -$8.97 million in FY2022 and -$19.49 million in FY2021.
- Quarterly Equity Income has run from a low of -$38.02 million in Q4 2021 to a high of $34.61 million in Q1 2023 over five years.
- On a year-over-year basis, Equity Income increased in four of the last five quarters, with growth averaging 62.6%.
- According to Business Quant data, Equity Income for the three prior quarters was $21.76 million (Q1 2026), $4.01 million (Q4 2025) and $15.95 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Rocket Companies | 43.26 Bn | 28.94 Bn | - | - |
| 2 | Orix | 42.40 Bn | 42.90 Bn | - | 403.49 Mn |
| 3 | Royalty Pharma | 33.56 Bn | 33.47 Bn | - | 4.08 Mn |
| 4 | Federal National Mortgage Association Fannie Mae | 24.47 Bn | 24.47 Bn | - | - |
| 5 | Affirm Holdings | 23.34 Bn | 17.03 Bn | - | - |
| 6 | Synchrony Financial | 23.06 Bn | -44.91 Bn | - | - |
| 7 | Royal Gold | 19.98 Bn | 19.21 Bn | 390.45 Mn | - |
| 8 | Annaly Capital Management | 14.18 Bn | 5.27 Bn | - | - |
| 9 | Ares Capital | 13.71 Bn | 11.15 Bn | - | - |
| 10 | Federal Home Loan Mortgage | 12.39 Bn | -6.35 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.08 Mn |
| Mar 31, 2026 | 21.76 Mn |
| Dec 31, 2025 | 4.01 Mn |
| Sep 30, 2025 | 15.95 Mn |
| Jun 30, 2025 | 2.69 Mn |
| Mar 31, 2025 | 6.44 Mn |
| Dec 31, 2024 | 31.65 Mn |
| Sep 30, 2024 | 10.41 Mn |
| Jun 30, 2024 | 1.70 Mn |
| Mar 31, 2024 | -14.15 Mn |
| Dec 31, 2023 | 268,000.00 |
| Sep 30, 2023 | -5.22 Mn |
| Jun 30, 2023 | -770,000.00 |
| Mar 31, 2023 | 34.61 Mn |
| Dec 31, 2022 | -6.86 Mn |
| Sep 30, 2022 | -3.25 Mn |
| Jun 30, 2022 | 737,000.00 |
| Mar 31, 2022 | 397,000.00 |
| Dec 31, 2021 | -38.02 Mn |
| Sep 30, 2021 | 2.75 Mn |
API Access
Royalty Pharma Equity Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=equity-income&ticker=RPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "equity-income", "ticker": "RPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=equity-income&ticker=RPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();